Changes to antiretroviral drug regimens during integrated TB-HIV treatment: Results of the SAPiT trial

BACKGROUND: Frequency of drug changes in combination antiretroviral therapy among patients starting both tuberculosis (TB) and human immunodeficiency virus (HIV) therapy, as a result of treatment-limiting toxicity or virological failure, is not well established. METHODS: Patients in the Starting Ant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Naidoo, Anushka, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Gengiah, Tanuja N, Padayatchi, Nesri, Gray, Andrew L., Bamber, Sheila, Nair, Gonasagrie, Karim, Salim S Abdool
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3984627/
https://ncbi.nlm.nih.gov/pubmed/24176943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2701
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak